Open AccessCan subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial
Author(s) -
Hatice Selen Kanar,
Aysu Karatay Arsan,
Ahmet Altun,
Suat Akı,
Aynur Hacısalihoğlu
Publication year - 2020
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_350_19
Subject(s) - medicine , aflibercept , combination therapy , diabetic macular edema , ophthalmology , visual acuity , macular edema , randomized controlled trial , prospective cohort study , diabetic retinopathy , diabetes mellitus , surgery , bevacizumab , chemotherapy , endocrinology
To compare the efficacy of subthreshold micropulse yellow laser (SMYL) and intravitreal aflibercept injection (IAI) combination therapy with IAI monotherapy in the treatment of diabetic macular edema (DME) and to evaluate the number of injections and SMYL sessions required.